30.08.2010 • NewsPotashBHP Billiton

No Threat From Potash Bid Battle

Potash miner K+S is specialised enough to weather any takeover of Canadian rival Potash and survive as a standalone entity, the German firm's finance director told a newspaper.

Potash is facing a hostile $39 billion bid from BHP Billiton. The Canadian firm's shares have traded well above the $130 that the offer represents, suggesting investors believe BHP will boost its offer or a rival bidder will emerge. "We are following the latest developments ... calmly," Jan Peter Nonnenkamp told Boersen Zeitung newspaper in an interview published on Saturday.

Asked if K+S, the world's fourth-largest potash miner, should act to ensure it does not become a takeover target, he said: "A change of ownership at (Potash) would not create new capacity."

"The worldwide potash market would continue to offer sufficient space for K+S. That is true for standard products, but particularly more so for our  specialty products," he said. "In the past few years, K+S was able to assert itself very successfully against export cartels like Canpotex or BPC."

Nonnenkamp said K+S would continue to create value for shareholders, which was "the best protection against takeovers."

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.